Cancer_Heme Malignancy Tumor Board

Occurs weekly every Thursday starting on 1/16/2025 at 12:00 PM
Thursday, January 16, 2025, 12:00 PM - 1:00 PM, Other, Cleveland, OH


AMA PRA Category 1 Credits™ (1.00 hours), Non-Physician Attendance (1.00 hours)

Series of multidisciplinary case conferences to review neuro oncology cases and discuss treatment plans

1. Discuss and collaborate on individual patient cases, ensuring a comprehensive, evidence-based, and personalized treatment plan tailored to the patient's specific cancer diagnosis, stage, and overall health.
2. Review complex or challenging cancer cases, integrating the expertise of specialists in various fields to guide clinical decision-making, improve diagnostic accuracy, and select the most appropriate therapeutic interventions, such as surgery, chemotherapy, radiation, or targeted therapy.
3. Facilitate continuous learning among healthcare providers by discussing the latest advancements in cancer treatment, emerging clinical trials, and novel therapeutic approaches, thereby improving the quality of care and ensuring the team is up-to-date with current best practices in oncology.

The MetroHealth System is accredited by the Ohio State Medical Association to provide continuing medical education for physicians.

Cancellation Policy

Cancellations received in writing no less than 20 days before the course will be refunded, less a 20% administrative fee. No refunds will be made on cancellations received after that date. Please send cancellation requests to [email protected].

The MetroHealth System reserves the right to cancel or postpone this program if necessary; in the event of cancellation, course fees will be fully refunded. We are not responsible for other costs incurred such as non-refundable airline tickets or hotel penalties.

Accessibility Statement
 
The MetroHealth System is committed to ensuring that its programs, services, goods and facilities are accessible to individuals with disabilities as specified under Section 504 of the Rehabilitation Act of 1973 and the Americans with Disabilities Amendments Act of 2008.  If you have needs that require special accommodations, including dietary concerns, please contact the CME Conference Coordinator.

The MetroHealth System adheres to ACCME Criteria, Standards and Policies regarding industry support of continuing medical education. Disclosure of faculty and their commercial relationships will be made prior to the activity.

Mitigation of Relevant Financial Relationships

The MetroHealth System adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including Faculty, planners, reviewers, or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

Date	Empty Column	Title
8/15/2025 7:00:00 AM	Cancer_Heme Malignancy Tumor Board Q3 Survey - Aug 2025 8/15/2025 7:00:00 AM 8/15/2025 8:00:00 AM 15 Other False MM/DD/YYYY	Cancer_Heme Malignancy Tumor Board Q3 Survey - Aug 2025 Series of multidisciplinary case conferences to review neuro oncology cases and discuss treatment plans Location: Other Specialties: All Specialties, Anesthesiology, Dentistry, Dermatology, Emergency Medicine, Endocrinology, Family Medicine, Gastroenterology, Geriatrics, Infectious Diseases, Internal Medicine, Medicine / Pediatrics, Nephrology, Neurology, Neurosurgery, Obstetrics/Gynecology, Orthopaedics, Otolaryngology, Pain Management & Rehabilitation, Pathology, Pediatrics, Psychiatry, Radiology, Rheumatology, Surgery